What's New on the FDA Drugs Site
April 24, 2017
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- C.O. Truxton, Inc. Issues Voluntary Nationwide Recall of Phenobarbital 15 mg Tablets, USP due to Labeling Error on Declared Strength
- Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act (updated)
- Extending Expiration Dates of Doxycycline Tablets and Capsules in Strategic Stockpiles Draft Guidance for Government Public Health and Emergency Response Stakeholders (PDF - K226B)
- FDA Drug Shortages
- Methotrexate Sodium Injection (New - Currently in Shortage)
- Hospira Issues a Voluntary Nationwide Recall For One Lot Of 25% Dextrose Injection, USP (Infant) Due To The Presence of Particulate Matter
- Office of Surveillance and Epidemiology (OSE) - Divisions - Organization Chart (updated)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
- Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505A and 505B of the Federal Food, Drug, and Cosmetic Act, as amended by the FDA Safety and Innovation Act of 2012 (FDASIA) (updated)
.png)
No hay comentarios:
Publicar un comentario